NYLOXIN

Serial Number 98486577
600

Registration Progress

Application Filed
Apr 5, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

NYLOXIN

Basic Information

Serial Number
98486577
Filing Date
April 5, 2024
Abandonment Date
May 12, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
600
Status Date
May 15, 2025
Classes
005

Rights Holder

NUTRA PHARMA CORP.

03
Address
6400 Park of Commerce Blvd, Suite 1B
Boca Raton, FL 33487

Ownership History

NUTRA PHARMA CORP.

Original Applicant
03
Boca Raton, FL

Legal Representation

Attorney
Antoine Wade

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Jul 14, 2025 TPDR I TEAS PETITION TO DIRECTOR RECEIVED Loading...
May 15, 2025 MAB0 E ABANDONMENT NOTICE E-MAILED - INCOMPLETE RESPONSE Loading...
May 12, 2025 ABN0 O ABANDONMENT - INCOMPLETE RESPONSE Loading...
Apr 25, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 25, 2025 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Apr 25, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 10, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Feb 10, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Feb 10, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jan 21, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 21, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 21, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 21, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 21, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 21, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 20, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 5, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Analgesics; capsules containing analgesics; oral analgesics, namely, oral drinks and oral sprays for pain relief; nasal spray preparations; topical gels, sprays, and lotions for medical and therapeutic treatment of pain
First Use Anywhere: Sep 1, 2010
First Use in Commerce: Sep 1, 2010

Classification

International Classes
005